WAY-620057

CAS No. 32585-54-9

WAY-620057( —— )

Catalog No. M28484 CAS No. 32585-54-9

WAY-620057 is an inhibitor that target protein-protein interactions in RAD51 family of recombinases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 243 In Stock
5MG 249 In Stock
10MG 369 In Stock
25MG 562 In Stock
50MG 770 In Stock
100MG 1032 In Stock
200MG 1376 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WAY-620057
  • Note
    Research use only, not for human use.
  • Brief Description
    WAY-620057 is an inhibitor that target protein-protein interactions in RAD51 family of recombinases.
  • Description
    WAY-620057 is an inhibitor that target protein-protein interactions in RAD51 family of recombinases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    MPO
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    32585-54-9
  • Formula Weight
    300.38
  • Molecular Formula
    C16H16N2O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=S(=O)(NCCc1c[nH]c2ccccc12)c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Caffeoylcalleryanin

    Caffeoylcalleryanin exerted strong 15-LOX inhibitory activity; IC50 values was 1.59 μM.A. pulchra leaves ethanol extract (EEAPL) affords compounds with antiviral activity, mainly against DENV-2. respectively, while Caffeoylcalleryanin was the most effective anti-DENV-2 constituent, with a SI of 20.0.

  • BI-0474

    BI-0474 is a potent KRASG12C inhibitor that inhibits GDP-KRAS::SOS1 protein-protein interactions with an IC50 value of 7.0 nM.BI-0474 exhibits significant antiproliferative activity against NCI-H358 cells harboring the G12C mutation, and shows significant anti-tumor activity in a non-small cell lung cancer xenograft model.

  • Pyrabactin

    Pyrabactin is a seed-selective abscisic acid (ABA) agonist, Novel PYL agonist; acting as a plant growth inhibitor.